Do long-acting beta2-adrenergic agonists deserve a different place in guidelines for the treatment of asthma and COPD?
- PMID: 10780751
- DOI: 10.1034/j.1399-3003.2000.15d02.x
Do long-acting beta2-adrenergic agonists deserve a different place in guidelines for the treatment of asthma and COPD?
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical